The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about many questions as hospitals and blood centers prepare to order the testing. We've put together a FAQ document to clarify what we know today. We will update the document as we get more information on existing questions and as new questions get asked, and will update the blog with the revised FAQ document.
Thanks for your support as we work to rapidly get this testing available to you. You can find the FAQ document here: CTS COVID-19 Questions and Answers
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...